CEBPB and neoplasm: These data suggest that C/EBPβ is able to both inhibit the growth of the bulk of the tumor, characterized by actively cycling cells, but also to hinder the growth and motility of glioblastoma stem cells characterized by a low rate of division and high metastatic capacity.